PROFESSIONAL EDITION

The largest community of pharma leaders

REUTERS: Australian firm says its nasal spray reduced coronavirus growth in animal study

SYDNEY (Reuters) – Australian biotech company Ena Respiratory said on Monday that a nasal spray it is developing to improve the human immune system to fight common cold and flu significantly reduced the growth of the coronavirus in a recent study on animals.

A study on ferrets showed the product dubbed INNA-051, which could be used complementary to vaccines, lowered the levels of the virus that causes COVID-19 by up to 96%, the company said. The study was led by British government agency Public Health England.

 

More: https://www.reuters.com/article/us-health-coronavirus-australia-nasalspr/australian-firm-says-its-nasal-spray-reduced-coronavirus-growth-in-animal-study-idUSKBN26J04T

Recent Articles